A Phase 1/2, Multi-Center, Dose-Escalating Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Quizartinib Administered in Combination with Re-Induction Chemotherapy, and as a Single-Agent Maintenance Therapy, in Pediatric R

Project: Research project

Description

A Phase 1/2, Multi-Center, Dose-Escalating Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Quizartinib Administered in Combination with Re-Induction Chemotherapy, and as a Single-Agent Maintenance Therapy, in Pediatric R
StatusActive
Effective start/end date10/23/1910/22/20

Funding

  • Children's Hospital of Philadelphia

Fingerprint

Induction Chemotherapy
Pharmacokinetics
Pediatrics
Safety
Therapeutics
quizartinib